The company
BeOne Medicines Ltd. - American Depositary Shares
ONC · Nasdaq
ONC stood above a rising 150-day average in 28 of the last 52 weekly readings, including each of the last 11 weeks. It is 20.4% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 11 in a row
- Industry in uptrend
- 18% -12 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $709.4M
- Officials’ trades on record
- 0
- Institutions holding
- 273 (+4)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 28 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Xiaodong WangDirector, Other | sold | 7,167at $349.56 | 13 Oct 2026filed 15 Oct 2026 |
| Xiaodong WangDirector, Other | sold | 10,361at $350.47 | 13 Oct 2026filed 15 Oct 2026 |
| Xiaodong WangDirector, Other | sold | 5,681at $351.40 | 13 Oct 2026filed 15 Oct 2026 |
| Xiaodong WangDirector, Other | sold | 6,558at $352.57 | 13 Oct 2026filed 15 Oct 2026 |
| Xiaodong WangDirector, Other | sold | 1,260at $353.24 | 13 Oct 2026filed 15 Oct 2026 |
| Chan Henry LeeSVP, General Counsel | sold | 1,115at $375.00 | 30 Sep 2026filed 2 Oct 2026 |
| Xiaodong WangDirector, Other | sold | 160at $356.97 | 28 Sep 2026filed 30 Sep 2026 |
| Xiaodong WangDirector, Other | sold | 120at $358.71 | 28 Sep 2026filed 30 Sep 2026 |
| Xiaodong WangDirector, Other | sold | 40at $359.16 | 28 Sep 2026filed 30 Sep 2026 |
| Xiaodong WangDirector, Other | sold | 2,241at $361.05 | 28 Sep 2026filed 30 Sep 2026 |
| Xiaodong WangDirector, Other | sold | 4,239at $362.17 | 28 Sep 2026filed 30 Sep 2026 |
| Xiaodong WangDirector, Other | sold | 3,499at $363.10 | 28 Sep 2026filed 30 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BAKER BROS. ADVISORS LPadded · filed 14 Aug 2026 | 8,801,567$2.5B | +2,5140.0% |
| PRIMECAP MANAGEMENT COadded · filed 14 Aug 2026 | 5,007,931$1.4B | +32,750+0.7% |
| Capital International Investorsadded · filed 12 Aug 2026 | 4,210,221$1.2B | +51,495+1.2% |
| FMR LLCreduced · filed 13 Aug 2026 | 2,478,527$706.3M | -1,215,083−32.9% |
| Capital World Investorsadded · filed 12 Aug 2026 | 2,249,582$641.1M | +626,895+38.6% |
| CITADEL ADVISORS LLCadded · filed 14 Aug 2026 | 1,425,517$406.2M | +393,219+38.1% |
| Temasek Holdings (Private) Ltdreduced · filed 7 Aug 2026 | 845,729$241.0M | -16,914−2.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 694,618$197.9M | +37,117+5.6% |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 543,323$154.8M | +338,477+165.2% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 497,437$141.8M | +32,965+7.1% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.